← Back to Directory

Kaleido Biosciences, Inc. (KLDO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Kaleido Biosciences, Inc. (KLDO).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Details

Price & Market Data

Price: $0.0₃1

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $4,262

Daily Volume: 0

About Kaleido Biosciences, Inc. (KLDO)

Understand Kaleido Biosciences, Inc. (KLDO)'s current market standing. Current price: 0.0₃1, daily change: $0.00 / 0.00%. Market cap: 4,262. Detailed performance for all periods.

Details

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of ulcerative colitis, psoriasis, atopic immune disease, chronic obstructive pulmonary disease pathogens, and immuno-oncology. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Selected stocks

Universal Robina (UVRBF)

Fannie Mae (FNMFO)

Los Andes Copper Ltd. (LSANF)

HALL OF FAME BEVERAGES INC (HFBG)

ATLAS SALT INC. (SALQF)